BUSINESSJun 3 · 04:14 UTCSCMP WORLDZhang Shidong

Chinese biotech GenScript surges as it rebuffs US lawmakers’ allegations

GenScript Biotech Holdings' shares surged in Hong Kong after the company pushed back against US lawmakers' allegations of national security concerns. The stock rose over 18% despite the Hang Seng Index declining 1.6%.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GenScript Biotech HoldingsorganizationUS lawmakersorganizationHong KongplaceHang Seng Indexorganizationnational securitytopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

SECURITYJun 1 · 22:30 UTC
China's biotech boom alarms Western lawmakers, investors
HEALTHMay 20 · 13:55 UTC
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
BUSINESSApr 17 · 17:41 UTC
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
BUSINESSMay 18 · 13:11 UTC
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
BUSINESSMay 26 · 11:50 UTC
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
BUSINESSMay 12 · 01:20 UTC
DroneShield Plunges as Regulator Probes Filings, Share Trades